Clinical Trial Update: Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients [Phase 1]

View source ↗

Summary

This is a completed Phase 1 trial evaluating the pharmacokinetics and safety of the investigational compound M518101 in patients with plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• M518101

Snippet

Sponsor: Maruho North America Inc. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED